Structure of the foot-and-mouth disease virus leader protease: a papain-like fold adapted for self-processing and eIF4G recognition by Guarné, Alba et al.
The EMBO Journal Vol.17 No.24 pp.7469–7479, 1998
Structure of the foot-and-mouth disease virus leader
protease: a papain-like fold adapted for
self-processing and eIF4G recognition
Alba Guarne´, Jose´ Tormo,
Regina Kirchweger1,2, Doris Pﬁstermueller1,
Ignasi Fita and Tim Skern1,3
Centre d’Investigacio´ i Desenvolupament (CSIC), Jordi Girona
Salgado 18–26, E-08034 Barcelona, Spain and 1Institute of
Biochemistry, Medical Faculty, University of Vienna,
Dr Bohr-Gasse 9/3, A-1030 Vienna, Austria
2Present address: Department of Cell Biology and Genetics,
Sloan Kettering Memorial Cancer Center, East 68th Street, New York,
NY, USA
3Corresponding author
e-mail: timothy.skern@univie.ac.at
The leader protease of foot-and-mouth disease virus,
as well as cleaving itself from the nascent viral poly-
protein, disables host cell protein synthesis by specific
proteolysis of a cellular protein: the eukaryotic initi-
ation factor 4G (eIF4G). The crystal structure of the
leader protease presented here comprises a globular
catalytic domain reminiscent of that of cysteine
proteases of the papain superfamily, and a flexible
C-terminal extension found intruding into the sub-
strate-binding site of an adjacent molecule. Neverthe-
less, the relative disposition of this extension and the
globular domain to each other supports intramolecular
self-processing. The different sequences of the two
substrates cleaved during viral replication, the viral
polyprotein (at LysLeuLys↓GlyAlaGly) and eIF4G (at
AsnLeuGly↓ArgThrThr), appear to be recognized by
distinct features in a narrow, negatively charged groove
traversing the active centre. The structure illustrates
how the prototype papain fold has been adapted to the
requirements of an RNA virus. Thus, the protein
scaffold has been reduced to a minimum core domain,
with the active site beingmodified to increase specificity.
Furthermore, surface features have been developed
which enable C-terminal self-processing from the viral
polyprotein.
Keywords: crystallography/cysteine proteases/
picornavirus/RNA viruses/translational control
Introduction
The structures of a number of viral proteases have been
determined recently (Babe´ and Craik, 1997). Comparison
of these viral structures with those of prototypes of the
four classes of proteases reveals similarities, but also
distinct differences in mechanism and structure. Thus, the
picornaviral 3C cysteine protease and the NS3 serine
protease of hepatitis C virus have a similar fold to the
serine protease trypsin (Allaire et al., 1994; Matthews
et al., 1994; Kim et al., 1996; Love et al., 1996). In
contrast, the cytomegalovirus protease possesses a single
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β-barrel structure, instead of the classic two β-barrel motif
of trypsin, and a novel catalytic triad of His/His/Ser (Chen
et al., 1996; Tong et al., 1996). Furthermore, the adenovirus
protease, a viral cysteine protease, also has a novel
fold, although it employs a catalytic triad Asp/His/Cys
reminiscent of that found in the cysteine protease papain
(Ding et al., 1996). Papain-like cysteine proteases are
characterized by a tryptophan residue following the nucleo-
philic cysteine, and two hydrophobic residues following
a conserved histidine which increases the nucleophilic
character of the catalytically active cysteine (Berti and
Storer, 1995). Indeed, a number of viral proteolytic
enzymes have been proposed to be papain-like cysteine
proteases, based mostly on the presence of such conserved
patterns (Gorbalenya et al., 1991). However, the lack
of direct structural information on these viral cysteine
proteases has prevented the establishment of further rela-
tionships between papain and its putative viral relatives.
The leader protease (Lpro) of foot-and-mouth disease
virus (FMDV), an animal pathogen of global importance,
is a proposed papain-like viral cysteine protease. Even
though sequence identity between the FMDV Lpro and
papain is no higher than 15% (Gorbalenya et al., 1991;
Skern et al., 1998), the characteristic residues of papain-
like proteases are conserved in the primary sequences of the
Lpro from both FMDV and the related equine rhinoviruses
(ERVs). Lpro is the first protein encoded on the FMDV
polyprotein (Figure 1A). Its sole role in viral maturation
is to free itself from the polyprotein by cleavage between
its own C-terminus and the N-terminus of VP4 (Figure
1B) at the sequence ArgLys LeuLys↓GlyAlaGlySer. The-
oretically, this self-processing event can occur either intra-
or intermolecularly (Figure 1B); expression of the Lpro in
various in vivo and in vitro systems has provided evidence
for both types of reaction (Belsham et al., 1990; Medina
et al., 1993; Piccione et al., 1995b). Nevertheless, it has
not yet been established which of the two mechanisms
for self-processing is preferred in vivo. As initiation of
protein synthesis on the FMDV genome occurs at one of
two AUG codons lying 84 nucleotides apart, two species
of Lpro (known as Labpro and Lbpro, depending on whether
protein synthesis initiates at the first or second AUG
codon, respectively) have been identified in infected cells
and have been shown to possess the same enzymatic
properties (Medina et al., 1993). In addition to LbPro,
FMDV encodes two other proteolytic activities, the 2A
peptide which has been proposed to cleave autocatalyt-
ically between its own C-terminus and the N-terminus of
2B, and the 3C protease (Ryan and Flint, 1997). This
enzyme carries out all remaining cleavages, with the
exception of that between VP4 and VP2 which occurs in
the maturing capsid by an as yet unknown mechanism.
After the single self-processing event, Lpro then plays
a central role in FMDV replication by specifically cleaving
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Fig. 1. Schematic drawing of the biological activities of Lpro. (A) The RNA genome of FMDV. The single open reading frame is shown as an open
box (with the mature viral proteins indicated), non-coding regions by a line and the IRES with a closed box. Lpro forms are stippled. (B) Protein
synthesis on FMDV mRNA; Lpro self-processing is indicated as an intra- or intermolecular event. (C) Role of eIF4 proteins in initiation of protein
synthesis and cleavage of eIF4G by Lbpro. eIF4 proteins involved in protein synthesis and the 40S ribosomal subunit are indicated. The m7GDP
5 cap structure of cellular mRNAs (open circle) and the Lbpro cleavage site (arrow) are indicated. The eIF4G C-terminal domain still forms an
initiation complex with IRES-containing mRNAs.
the host cell protein eukaryotic initiation factor eIF4G at
the sequence AlaAsnLeuGly↓ArgThrThrLeu (Figure 1C;
Kirchweger et al., 1994). As a result, the domain of eIF4G
which binds the cap-binding protein eIF4E is separated
from the domain of eIF4G which binds eIF3, so that the
infected cell is unable to recruit its own capped mRNA
to the 40S ribosome. The viral mRNA is unaffected as it
initiates protein synthesis internally via an IRES
(Figure 1C). This shuts off cellular mRNA translation in
favour of the viral counterpart.
We report here the three-dimensional structure of two
variants of the FMDV Lbpro, present their relationship to
the papain superfamily and discuss mechanisms of self-
processing and the basis of substrate recognition for
specific cleavage on two different proteins.
Results and discussion
Structure determination
Wild-type Lbpro crystals could not be obtained. However,
substitution of the active site nucleophile Cys51 (Piccione
et al., 1995a; Roberts and Belsham, 1995; Ziegler et al.,
1995) with Ala allowed crystals to be grown as reported
(Guarne´ et al., 1996). These contained eight Lbpro mole-
cules in the asymmetric unit but were difficult both to
reproduce and to manipulate. Thus, although a native
diffraction data set from these crystals was obtained up
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to 3.0 Å resolution, the corresponding phases could not
be determined. We speculated that the properties of these
crystals resulted from interactions between the C-terminus
of one molecule and the active site of a neighbour, and
therefore prepared a truncated form of the inactive Lbpro
lacking six C-terminal amino acids (termed sLbpro). New
crystals were obtained containing two sLbpro molecules in
the asymmetric unit and the structure was solved by a
combination of isomorphous replacement and density
modification techniques. The Lbpro Cys51Ala mutant was
then determined by molecular replacement using the sLbpro
structure as a search model (Table I; see Materials and
methods).
Description of the overall Lbpro structure
The Lbpro structure (Figure 2A–C) presents a compact,
globular region, ranging from Met29 to Tyr183 with an
overall cubic shape of approximate edge dimensions of
30 Å, from which a flexible C-terminal extension (CTE)
ranging from Asp184 to Lys201 extrudes. The globular
region is divided into two subdomains, with the cata-
lytically essential residues Cys51 (replaced by Ala in the
Lbpro structure) and His148 located at the interface. The
first, N-terminal subdomain contains four α-helices (α1,
α2, α3 and α4) and two short antiparallel β-strands
(β1 and β2) comprising only residues Glu30–Thr32 and
Lys38–Thr40, respectively. The longest α-helices α1 and
Crystal structure of the FMDV leader protease
Table I. X-ray parameters and refinement statistics
Lbpro sLbpro
Native HgCl2 K2PtCl4
Data collection #
Space group P212121 C2221 C2221 C2221
Resolution (Å) 25–3.0 25–3.0 25–2.7 25–2.8
No. of unique reflections 35 080 7339 9335 9083
Completeness (%) 92 (75) 84 (90) 82 (89) 94 (90)
I/σI 9.5 (3.0) 9.9 (4.4) 9.9 (7.4) 7.4 (4.1)
Multiplicity 7.7 6.0 8.3 9.6
Rsym (%) 10.3 (26.3) 9.3 (19.9) 8.5 (17.2) 9.7 (19.1)
MIR phasing (25.0–3.0 Å)a
Riso (%) 32.3 (38.4) 23.4 (30.3)
Sites 5 2
Phasing power 1.57 1.49
RCullis 0.68 0.79
Mean figure of merit 0.37 0.37
Model refinement (20.0–3.0 Å)
Rfactor % (Rfree, %) 25.8 (29.6) 23.5 (28.8)
No. of reflections 34 977 7320
Total no. of non-hydrogen atoms 11 190 2565
No. of solvent molecules 3 20
R.m.s. deviation in bonds (Å) 0.005 0.005
R.m.s. deviation in angles (°) 1.2 1.3
R.m.s. deviation in temperature (bonded atoms, Å2) 2.4 1.6
Anisotropic correction
(a*; b*, c*; Å2) 15.6; –16.9; 4.3 –1.3; 10.8; 9.2
Average B-factor (Å2) 38.8 25.6
aNumbers in parentheses correspond to the highest resolution shell (3.05–3.00 Å).
Rsym  Σ|I – I|/ ΣI, where I  observed intensity and I  averaged intensity obtained by multiple observations of symmetry related
reflections.
Riso  Σ|(|FPH| – |FP|)/Σ|FP|, where |FP|  protein structure factor amplitude and |FPH|  heavy-atom derivative structure factor amplitude.
Rcullis  Σ||FPH  FP||–FH(calc)||/Σ|FPH  FP| for all centric reflections.
α3 (comprising residues Asn50–Glu64 and Leu78–Gly91,
respectively) run perpendicular to each other, with the
catalytic Cys51 being located towards the N-terminal side
of helix α1. The shortest helix α2 spans only six residues
(Phe68–Ser73) and runs almost parallel to α3. The second
Lbpro subdomain displays a fold belonging to the all
β-family of proteins, as the only regular secondary struc-
ture elements are contained in a mixed β-sheet formed by
one parallel (β3 with β4) and six antiparallel (β4–β9)
β-strands (Figure 2A–C). The essential His148 is located
on the turn connecting the longest strands β5 and β6
(residues Phe137–Leu143 and Ala149–Thr155) which
occupy a central position in the sheet.
The main difference between the structures of Lbpro
and sLbpro is that, in the latter, the 12 residues remaining
in the CTE are disordered in both molecules present in
the asymmetric unit (from residue Asp184 onwards). The
superimposition of the globular regions of Lbpro and sLbpro
models gives an r.m.s. deviation of 0.4 Å (performed
using the program SHP; Stuart et al., 1979), which can
be considered as an upper limit for the coordinate errors
in the compact region of the two structures.
Several groups proposed a papain-like fold for the
picornaviral Lpro structure (Gorbalenya et al., 1991;
Piccione et al., 1995a; Skern et al., 1998). The papain-
fold consists of left- (L) and right-hand (R) domains
[standard papain-fold view (Kamphuis et al., 1985)] which
are structurally equivalent to the two subdomains described
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for Lbpro. Superimposition of main-chain Cα atoms from
Lbpro with papain (Figure 2A and D) gives an averaged
r.m.s. deviation of 1.3 Å for 76 equivalent residues.
As the globular region of Lbpro represents the smallest
polypeptide fragment with a papain-like topology, it lacks
most of the decoration found in papain, including the
prosegment-binding loop (PBL; Coulombe et al., 1996;
Figure 2D). Regions most conserved between the papain-
like proteases and Lbpro structures are located around the
active centre, especially secondary elements α1 and
β5–β6, containing the catalytic cysteine and histidine
residues (Figure 2B and C). Papain-like proteases have,
however, no equivalent to the Lbpro CTE.
The extended conformations of the Lbpro CTEs are
stabilized by a network of intermolecular interactions
originating from the exchange of the CTEs between
neighbouring molecules. In four out of the eight Lbpro
molecules in the asymmetric unit, all residues in the CTE
are visible (Figures 2C and 3) while, in the other four
molecules, there is some disorder, and residues Glu186–
Glu191 have not been traced (Figures 2C and 3). In the
four molecules containing the disorder, the conformation
of the visible residues is closely related to, though subtly
different from that found in the other four (Figures 2B, C
and 3). The 10 C-terminal amino acids, residues Trp192–
Lys201, are nevertheless well defined in all eight crystallo-
graphically independent subunits and present identical
interactions with the substrate-binding pocket of adjacent
molecules in the crystal.
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Besides the exchange of the CTEs between neighbouring
molecules, the crystal packing of both Lbpro and sLbpro
forms shows a polymeric character brought about by
two noteworthy peculiarities. First, there is a covalent
intermolecular disulfide bridge between adjacent mole-
cules (Figure 3) in both the sLbpro and Lbpro forms,
although the spatial relationship between disulfide-linked
molecules differs in the two crystal forms. Secondly, there
is a large contact area of 1088 Å2 between the helical
domains of the neighbouring molecules which are related
by a local 2-fold axis. Again, the dimer defined by the
two subunits in contact is present in both the sLbpro and
the Lbpro crystal forms. However, as Lbpro functions
enzymatically as a monomer, the biological relevance of
both possible dimers is not clear.
The active site cleft
The active site containing the catalytic residues Cys51
and His148 is located on top of a deep cleft in the
interdomain region, as observed for other members of the
papain superfamily. Both the location of the active site
and the spatial arrangement of the catalytic residues
are well preserved (Figures 2B–D and 4A). In papain
superfamily members, the active site histidine (P-159;
papain numbering is used throughout when describing
papain-like proteases) is maintained in the correct orient-
ation with respect to the nucleophilic cysteine (P-25) by
a hydrogen bond to the side-chain oxygen of a conserved
asparagine residue (P-175). Asp163 carries out this task
in Lbpro (Figure 4A and B), and this residue is strictly
conserved in leader proteases (Figure 2A). In all members
of the papain superfamily examined so far, a tryptophan
residue (P-177) covers the hydrogen bond formed between
the Asn–His pair (Figure 4C); substitution of Trp P-177
reduces papain activity (Berti and Storer, 1995). Neither
this aromatic residue nor the 11 residue loop (P-175–
P-185) that anchors it in the papain-like enzymes is found
in Lbpro. In its place is a β-turn containing a cluster of
four acidic residues (Asp163, Asp164, Glu165 and
Asp166; Figure 4B); these residues confer a strong local
negative charge, so that the environment is quite different
from those in most papain-like enzymes (Figure 5). In the
absence of the tryptophan residue, the carboxylate group
of Asp163 may be required to form a stronger hydrogen
bond with His148. Despite these differences, Lbpro repre-
sents a papain-like enzyme without this fully conserved
tryptophan residue.
Another important catalytic residue in papain super-
family members is a conserved glutamine (P-19) whose
side-chain amide, together with the main-chain nitrogen
of the catalytic cysteine (P-25), stabilizes the negative
charge developing on the scissile carbonyl oxygen during
nucleophilic attack. This structural feature, termed the
oxyanion hole, is also present in Lbpro. However, Asn46
replaces the conserved glutamine residue (Figure 4B and
C). In Lbpro, the arrangement of the turn positioning Asn46
and the orientation of its side-chain amide [flipped by
180° compared with the equivalent glutamine (P-19) in
all other papain-like proteases] differ from those of other
members of the papain superfamily (compare Figure 4B
and C). This is probably due to the fact that, in Lbpro,
only four residues separate Asn46 from Cys51, whereas
five residues are found in other papain-like proteases. The
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shorter side chain of Asn46 and its orientation are required
because the tighter turn of the Lbpro brings the main chain
closer to the catalytic residues than in other papain-like
enzymes. The orientation of the side chain of Asn46 is
fixed by hydrogen bonds to the main-chain nitrogen of
Asp49, forming an Asn-pseudoturn, and the side-chain
carboxylate of Asp164 (Figure 4B). This aspartate residue,
conserved in all Lbpro sequences analysed so far (Figure
2A), is located immediately after the catalytic Asp163 in
the acidic loop described above, and participates in an
intricate network of hydrogen bonds involving residues
Asn46, Asp49, Asn54 and Asp164 (Figure 4B). This
network might contribute to the stability of the active site
structure and catalytic activity.
Fig. 2. Overall view of the FMDV Lpro and its relationship to papain.
(A) Structure-based amino acid alignment from the indicated FMDV
serotypes and ERV1. The alignments of FMDV serotypes are based on
those of Ryan and Flint (1997), that of ERV1 is from Skern et al.
(1998). Structurally equivalent residues in papain are shown. The
N-terminal positions of Labpro and Lbpro, secondary structure elements
and the start of the CTE are also indicated. Asterisks mark Asn46,
Cys51, His148 and Asp163. (B and C) Views of the structure of the
FMDV Lbpro rotated 90°. α-helices and β-strands are coloured green
and magenta, respectively. The active site Cys51 and His148 are
shown as balls and sticks. The ordered CTE is in orange (referred to
as CTE1), that containing the disordered amino acids (dashed lines) is
in blue (referred to as CTE2). (D) Stereo drawing of superimposed Cα
traces of Lbpro (blue) and papain (yellow), using the standard view of
papain (Kamphuis et al., 1985). The location of the prosegment-
binding loop (PBL) of papain is indicated (see text). [Figure 2B–D as
well as all parts of Figures 3 and 4 were drawn using the programs
MOLSCRIPT (Kraulis, 1991), with modifications by R.Esnouf
(Esnouf, 1997), and RASTER3D (Merrit and Murphy, 1994).]
Crystal structure of the FMDV leader protease
The interaction between Lpro and its C-terminus
FMDV Lpro frees itself from the growing polypeptide
chain by specific cleavage at its own C-terminus (Figures
1A,B and 2A). Thus, the presence of CTE residues
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inside the substrate-binding pockets of adjacent molecules
illustrates substrate recognition during self-processing and
represents, in fact, the P side of the substrate in the self-
processing reaction. The peptide backbone of the final
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Fig. 3. Stereo view of the disposition of the Lbpro molecules in the crystal. The eight Lbpro molecules contained in the asymmetric unit are coloured.
The orientation of the unit cell axis is also indicated. Four molecules, with the ordered CTEs, are shown in yellow, while the remaining four, with
the disordered CTE, are shown in green. The corresponding CTEs are shown in orange and blue, respectively. Six intermolecular disulfide bridges,
represented as thick balls, can also be seen, four of them with molecules of adjacent asymmetric units (in grey). The quasipolymeric character of the
packing, with extensive non-covalent interactions alternating with disulfide bridges, is apparent. Two types of non-crystallographic symmetries are
present. The first (dashed red lines) relates pairs of neighbouring molecules, whilst the second (red spot) relates four molecules of the asymmetric
unit with the other four.
residues of the CTE is in an extended conformation
(Figure 3) similar to that observed in complexes of
enzymes of the papain superfamily with peptide-like
inhibitors (Yamamoto et al., 1991, 1992).
The main interactions between the CTE and the sub-
strate-binding site (Figure 6) are provided by Lys201 and
Leu200, with minor contributions from residues Lys199–
Val196 (residues in the CTE of a symmetry-related
molecule are labelled with primed numbers). The final
CTE residue, Lys201, is positioned close to the active
site Cys51 (replaced by Ala in this structure) as if catalysis
had been completed. One of its carboxylate oxygens,
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located in the oxyanion hole, is hydrogen bonded to the
side chain of Asn46 and the main-chain nitrogen of Cys51,
whereas the second carboxylate oxygen accepts a hydrogen
bond from the imidazole ring of the catalytic His148
(Figure 6), expected to be protonated as described for
papain (Yamamoto et al., 1991; Brocklehurst et al., 1998).
The CTE establishes additional interactions with the
substrate-binding site through hydrogen bonds between
main-chain atoms. Thus, the main-chain nitrogen of
Lys201 forms a hydrogen bond with the main-chain
carbonyl of Glu147; the main-chain oxygen and nitrogen
atoms of Leu200 are hydrogen bonded to the main-chain
Crystal structure of the FMDV leader protease
Fig. 4. Active site of Lbpro. (A) Arrangement of amino acid side chains around the active site (viewed down through the central helix α1) after
superimposition of papain (grey) and Lbpro (green) using the program SHP (Stuart et al., 1979). Catalytic residues of Lbpro (Asn46, Cys51, His148
and Asp163) are in yellow, those of papain (Gln P-19, Cys P-25, His P-159 and Asn P-175) in grey. (B) Network of hydrogen bonds in the Lbpro
active centre. The acidic cluster (Asp163–Asp166) in the S-binding region is also shown. The orientation of the amide group of Asn46 is
maintained by hydrogen bond interactions with the main-chain nitrogen of Asp49 and the side chains of Asn54 and Asp164. (C) Hydrogen bonds in
the papain active centre. The fully conserved Trp P-177, in papain-like enzymes, covering the hydrogen bond between essential catalytic residues
Asn P-175 and His P-159 is also shown.
Fig. 5. Electrostatic potential surfaces of, left to right, papain (Kamphuis et al., 1984; 1pap PDB code), Lbpro and cathepsin L (Coulombe et al.,
1996; 1aec PDB code). The yellow arrow indicates the Lbpro active centre. The standard papain view is used in the top panel; that in the lower
panel, obtained by a simple 90° rotation of the upper one, is down the α1 helix. The apparent differences in charge distribution reflect the indicated
differences in isoelectric points, but also the different specificity of S and S subsites. [Figures 5 and 7 were generated by GRASP (Nicholls et al.,
1991)].
nitrogen and oxygen, respectively, of Gly98, building a
short antiparallel β-sheet. These hydrogen bond inter-
actions are a conserved feature in substrate binding by
papain superfamily members.
The S1 subsite in Lbpro is a narrow cleft bounded by
the loop preceding the central helix α1 on one side, the
β-turn connecting strands β5 and β6 on the other side and
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the active site at the bottom (Figures 2B and 6A,B). In
the Lbpro structure, the aliphatic portion of the side chain
of Lys201, which occupies the S1 subsite, is sandwiched
between the main chain of residues His95–Glu96 and the
side chain of Glu147, while its amino group establishes
electrostatic interactions with the carboxylates of Glu96
and Glu147 (Figure 6A). The S1 subsite in papain and
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Fig. 6. Stereo view of the interactions between the CTE and the S site. (A) Residues involved in the formation of subsites S1–S6 are shown as balls
and sticks, with nitrogen atoms coloured in blue and oxygen atoms in red. Residues of the CTE are also shown and labelled Val196–Lys201.
(B and C) Residues involved in the formation of the S1 and S2 subsites, respectively, are shown as balls and sticks with their corresponding electron
density in light blue. The P1 (Lys201) and P2 (Leu200) residues of the CTE are also shown.
other family members is a wide, unrestricted pocket which
exerts relatively little influence on the substrate specificity
(Figure 5). In Lbpro, which clearly prefers lysine at P1 in
the self-processing reaction (Figure 2A), this subsite has
become narrower and deeper due to a rearrangement of
the loop connecting strands β5 and β6 on the R domain.
Amino acid sequence alignments and modelling of the
ERV1 Lpro imply a correlation between the side chain at
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P1 and that of residue 147. Thus, FMDV enzymes, with
lysine in P1, have a negatively charged glutamate at
position 147; in contrast, the corresponding residue in
ERV1, with serine at P1, is Gly149, shorter and not
charged (Figure 2A).
The side chain of Leu200 (P2) is completely buried in
a hydrophobic S2 pocket formed by Trp52, Gly97–Pro100,
Leu143, Glu147–Ala149 and Leu178 (Figure 6A and C).
Crystal structure of the FMDV leader protease
Fig. 7. Model for self-processing of the Lbpro in cis. The electrostatic potential surface of Lbpro with CTE residues Asp184–Asn189 and Lys195–
Lys201 as sticks. Coordinates from Lys195 to Lys201 correspond to a neighbouring molecule in the crystal. However, the orientation and the
proximity of this fragment to Asn189 points towards a simple, direct connection within the same molecule of Lbpro. This joining is indicated by
dashes in the left panel and modelled by explicitly including residues Gly189–Ala194 in the right one. Polar amino acids would be exposed to the
solvent, and only Trp192, pointing towards Trp105, appears to require minor rearrangements of the flexible and highly exposed Arg109. The green
arrow indicates the position of the side chain of Cys133.
The architecture of the Lbpro S2 subsite is very similar to
that of other papain superfamily proteases; in fact, the
residues defining the pocket in papain are identical to
those in Lbpro, with the exception of Leu143 which is
equivalent to Val P-133.
CTE residues Lys199 (P3) and Arg198 (P4) occupy
loose pockets on opposite faces of the cleft, in the S3 and
S4 subsites, respectively. The aliphatic portion of the side
chain of Lys199 makes van der Waals contacts with
main-chain atoms of residues Gly97–Gly98, and its amino
group interacts through a hydrogen bond with the main-
chain carbonyl group of Glu93 and through weak ionic
interactions with the side-chain carboxylates of Glu93 and
Glu96. Arg198 makes van der Waals contacts with
Gly98, Pro99, Leu143 and extensively with Gln146. Its
guanidinium group also hydrogen-bonds to the amide side
chain of Gln146. Residue Gln197 (P5) has its side chain
exposed to the solvent, but still contacts through its main
chain Pro99, thus making a very open subsite S5. Finally,
Val196 is buried in a hydrophobic cavity (subsite S6
formed by residues Pro99, Ala101, Val127 and Leu178),
located on the interdomain cleft, just underneath subsite S2.
Biological implications of the structure
Self-cleavage at the C-terminus. The presence of the
CTE in the active site of adjacent molecules argues for
intermolecular self-processing. However, although in the
crystal structure of Lbpro the CTE projects away towards
neighbouring molecules, instead of folding back into its
own substrate-binding cleft, several structural features
suggest that self-processing in cis is possible and might
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even be favoured. First, the interface between the globular
domains exchanging their CTEs is composed of weak
interactions, indicating that this region is not designed to
promote an intermolecular reaction. Secondly, residues
located immediately after Tyr183, at which point the
polypeptide chain leaves the globular region to begin the
CTE, favour a turn. Notably, Asp184 and Glu186 are
conserved in all serotypes of FMDV and in ERV1,
enabling the placement of a conserved hydrophobic residue
(Leu188) into a shallow hydrophobic pocket formed by
residues Ala118, Pro121, Thr130, Met132 and Cβ of
Asp136. This interaction leads the CTE polypeptide in a
direction compatible with both cis and trans self-pro-
cessing. A polar, highly flexible stretch (residues Asn189–
Glu191; modelled in Figure 7) should overcome the
distance between this pocket and the above-described
subsites in the substrate-binding cleft. A tryptophan residue
at position 192 (or the aromatic residue found in ERV1
Tyr201) would enhance self-processing in cis by stacking
its aromatic ring with the exposed and conserved Trp105
(ERV1 Tyr103) of the globular domain. Thus, the CTE
would reach subsite S6 (interaction with Val196) with
minor rearrangements of the main chain (Figure 7); the
electrostatic and van der Waals interactions of the CTE
with the substrate-binding cleft would maintain the correct
orientation for the self-processing in cis.
Why are intramolecular CTE interactions not observed
in the Lbpro crystal structure? First, the path of the
CTE to its ‘own’ active site is partially blocked by
the intermolecular disulfide bridge between neighbouring
molecules. This bond is not believed to be present in the
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reducing environment inside the cell. Secondly, crystal
packing requirements may have also favoured the observed
CTE interactions. Finally, the ability to cleave eIF4G
requires the CTE to be flexible and not remain in the
active site. Evidence for the flexible nature of the CTE is
provided by the lack of density in the sLbpro form and the
differences in the positions of certain residues in the
disordered form of the CTE. The disorder in the CTE also
appears to be energetically favoured, as freezing the
polar CTE in a fixed conformation would impose a high
entropic penalty.
Cleavage of eIF4G. The tendency of the CTE to leave
the active site of the same polypeptide chain after cis
cleavage is of significance for the recognition and cleavage
of eIF4G by Lbpro. Thus, the enzyme cannot be inhibited
by binding to its own C-terminus, which served as the
recognition site for the cleavage on the viral polyprotein.
However, as indicated above, this implies that the S site
does not provide sufficient interactions to maintain the
substrate in the active site; indeed, the absence of signific-
ant intramolecular product inhibition is probably a direct
result of this inability. Thus, to bind to its cleavage site
on eIF4G, which lacks a basic P1 residue, the enzyme
appears to employ the acidic patch of the S site (Figure
5) to provide an ionic interaction with the P1 Arg residue
of the cleavage site on eIF4G. Indeed, it is noteworthy
that all intermolecular substrates of Lbpro identified so far
in vitro contain basic residues at P1 or P2 or both, even
when the P1 residue is basic (data not shown). Taken
together, these observations suggest that a substrate con-
taining basic residues at both P1 and P1 should be an
optimized substrate for the Lbpro. As, however, no data
are available on the sequence preference of Lbpro on
peptide substrates, experiments are underway to investigate
this notion.
The acidic patch at the S site of Lbpr°, coupled with
the narrow cleft traversing the active site (Figures 5 and
6A), also appear to be the reasons why the Lbpro is clearly
much more specific than papain, although the two enzymes
possess an S2 pocket almost identical in composition and
topology. Thus, Lbpro does not cleave an immunoglobulin
molecule, a classic substrate of papain. Furthermore,
although eIF4G is an efficient substrate for papain, the
cleavage products are not the same as those of Lbpro
(B.Hampoelz and T.Skern, unpublished).
Summary
The FMDV Lbpro is the first crystal structure determined
of a viral papain-like cysteine protease. The structure
shows the interactions involved in C-terminal processing
which enable cleavage between a lysine and a glycine
residue to take place. In addition, examination of the
substrate-binding cleft indicates how the enzyme can carry
out the specific cleavage of the host protein eIF4G which,
in contrast, requires cleavage between a glycine and an
arginine residue.
Materials and methods
Protein expression, puriﬁcation and crystallization
The Cys51Ala mutant of the FMDV serotype O1k Lb
pro was expressed in
Escherichia coliBL21 (DE3) pLysS and purified as described (Kirchweger
et al., 1994). A variant of the Cys51Ala mutant lacking six amino acids at
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theC-terminus (sLbpro)wasexpressedandpurifiedsimilarly.Lbpro crystals,
belonging to space group P212121 with cell dimensions a  65.4 Å, b 
101.6 Å and c  277.0 Å, were obtained by vapour diffusion against
solutions containing 10% PEG 6000, 0.8 M MgCl2, 0.1 M Tris–HCl, pH
8.5. There are eight molecules in the asymmetric unit and an estimated
solvent content of 59%. sLbpro crystals, belonging to space group C2221
with unit cell dimensions of a  51.0 Å, b  130.0 Å and c  126.2 Å,
were grown from 8% PEG 4000, 0.2 M MgCl2, 0.1 M Tris–HCl, pH 8.5.
This crystal formhas twomolecules in theasymmetricunit andanestimated
solvent content of 55%. sLbpro crystals were harvested in solutions con-
taining 10% PEG 4000, 0.2 M MgCl2, 0.1 M Tris–HCl, pH 8.5, prior to
data collection or heavy atom screening.
The two heavy atom derivatives of the sLbpro crystal used for phase
determination were prepared by soaking at room temperature for 48 h in
the harvesting solution containing 0.1 mM HgCl2 or for 24 h in the
harvesting solution which had been adjusted to 10 mM K2PtCl4.
Data collection
For cryogenic X-ray data collection, native and derivative crystals were
soaked in harvesting solutions made up to 25% ethylene glycol and flash-
frozen under a stream of boiled-off nitrogen at 100 K (Oxford CryoSys-
tems). X-ray diffraction data sets were collected on MarResearch image
plate detector systems using a Rigaku RU-200B rotating anode and syn-
chrotron facilities at the X11 EMBL outstation (DESY, Hamburg). Data
were indexed, reduced, scaled andmergedwithDENZOandSCALEPACK
(Otwinowski and Minor, 1997) (Table I). Most subsequent calculations
were performed with the CCP4 Program Suite (Collaborative Computa-
tional Project Number 4, 1994).
Structure determination
The structure of the sLbpro crystal form was determined by multiple iso-
morphous replacement. Heavy atom sites were located by Patterson
methods and confirmed using cross-phased difference maps. Refinement
of heavy atom parameters and phase calculation were performed with
SHARP (de la Fortelle and Bricogne, 1997). Initial phases were calculated
at 3.0 Å (Table I), and were significantly improved using the density
modification procedures in SOLOMON. An electron density map calcu-
lated using these phases showed clear molecular boundaries and allowed
the identification of several secondary structure elements to which polyal-
anine chains were fitted. These elements and the positions of the heavy
atom substitutions were used to determine the position of the local 2-fold
axis relating the two molecules in the asymmetric unit. Masks covering
the monomer were created from skeletonized electron density and partial
models using MAMA (Kleywegt and Jones, 1994), edited interactively
with program O (Jones et al., 1991), and used for local averaging and
solvent flattening in further cycles of density modification performed with
DM (Cowtan, 1994). The final figure of merit for data in the range 25.0–
3.0 Å was 0.68. The resulting electron density map was used for model
building with program O. The initial model comprised 138 amino acid
residues for each of the two copies in the asymmetric unit and had a
crystallographic R-factor of 0.47 for all reflections in the resolution range
10.0–3.0 Å.
Initial phases for the Lbpro (residues 29–201) crystal formwere obtained
bymolecular replacementwith the sLbpro coordinates as amodel. Rotation/
translation parameters were calculated with 95% of data between 15 and
3.5 Å using the AMoRe package (Navaza, 1994), and the information
about the presence of a translational symmetry derived from the strong
peak found in the native Patterson at position u 0.5, v 0.5, w 0.225
(Navaza et al., 1998). Four independent solutions were found that generate
the second four by translation. The molecular replacement solution gave a
final correlation factor of 0.69 and an R-factor of 0.40 for data in the same
resolution range.
Reﬁnement
Refinement was done following standard protocols using iteratively pro-
gram X-PLOR (Bru¨nger, 1992) alternating with manual rebuilding in the
interactive graphics program O. For both crystal forms, bulk solvent,
overall anisotropic B-factor corrections and tight non-crystallographic
restraints were introduced based on the behaviour of the Rfree index (Table
I). The non-crystallographic restraints for the Lb crystal formwere applied
considering two groups of 4-fold symmetrically related molecules.
The refined atomic model for the sLbpro form comprises residues 29–
187 for both copies in the asymmetric unit and 20 ordered solvent molec-
ules, and has an R-factor of 23.5% (Rfree  28.8%) for all data between
20.0 and 3.0 Å. Of the non-glycine residues, 82.1% fall within the ‘most
favoured regions’ of the Ramachandran plot, on the higher side of accept-
able for a 3.0Å structure as defined by the programPROCHECK (Laskow-
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ski et al., 1994). The rest are inside the ‘additional allowed regions’, except
for Asp164 which presents good electron density and is located at position
i 1 of a type II β turn. No electron density is observed for residues 184–
187, which form part of the CTE and project away from the globular
catalytic domain. The remainder of the residues, apart from a few solvent-
exposed side chains, present well-defined electron density for both molec-
ules in the asymmetric unit.
The refined atomic model for the Lbpro form comprises residues 29–201
for four copies in the asymmetric unit while the other four do not include
residues 186–192. The N-terminal residue appears to be modified by a
well-defined acetyl group in the eight independent subunits. The present
model has an R-factor of 25.8% (Rfree 29.6%) for all data between 20.0
and 3.0 Å. No electron density is observed for residues 186–192 in copies
with the disordered conformation of the CTE; however, the remaining
residues, apart from a few solvent-exposed side chains, present well-
defined electron density for all molecules in the asymmetric unit.
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